Combined Dextran-Graft-Polyacrylamide/Zinc Oxide Nanocarrier for Effective Anticancer Therapy in vitro

Int J Nanomedicine. 2023 Aug 28:18:4821-4838. doi: 10.2147/IJN.S416046. eCollection 2023.

Abstract

Introduction: Cancer chemotherapy faces two major challenges - high toxicity of active substances and tumor resistance to drugs. Low toxic nanocarriers in combination with anticancer agents can significantly increase the effectiveness of therapy. Modern advances in nanotechnology make it easy to create materials with the necessary physical and chemical properties.

Methods: Two hybrid nanosystems of dextran-polyacrylamide/ zinc oxide nanoparticles (D-PAA/ZnO NPs) were synthesized in aqueous solution with zinc sulphate (D-PAA/ZnO NPs (SO42-)) and zinc acetate (D-PAA/ZnO NPs (-OAc)). The light absorption, fluorescence, dynamic light scattering and transmission electron microscopy for nanocomposite characterization were used. MTT, neutral red uptake and scratch assays were selected as fibroblasts cytotoxicity assays. Cytotoxicity was tested in vitro for normal fibroblasts, MAEC, prostate (LNCaP, PC-3, DU-145) and breast (MDA-MB-231, MCF-7) cancer cells lines. Immunocytochemical methods were used for detection of Ki-67, p53, Bcl-2, Bax, e-cadherin, N-cadherin and CD44 expression. Acridine orange was used to detect morphological changes in cells.

Results: The radius of ZnO NPs (SO42-) was 1.5 nm and ZnO NPs (-OAc) was 2 nm. The nanosystems were low-toxic to fibroblasts, MAEC. Cells in the last stages of apoptosis with the formation of apoptotic bodies were detected for all investigated cancer cell lines. Proapoptotic proteins expression in cancer cells indicates an apoptotic death. Increased expression of E-cadherin and N-cadherin was registered for cancer cells line LNCaP, PC-3, DU-145 and MCF-7 after 48 h incubation with D-PAA/ZnO NPs (SO42-).

Conclusion: The nanosystems were low-toxic to fibroblasts, MAEC. The D-PAA/ZnO NPs nanosystem synthesized using zinc sulphate demonstrates high cytotoxicity due to destruction of various types of cancer cells in vitro and potentially increases adhesion between cells. Thus, our findings indicate the selective cytotoxicity of D-PAA/ZnO NPs against cancer cells and can be potentially used for cancer treatment.

Keywords: breast cancer; cytotoxicity; drug delivery; polymer nanocarrier; prostate cancer; zinc oxide nanoparticles.

MeSH terms

  • Acrylic Resins
  • Dextrans
  • Humans
  • Male
  • Zinc Oxide*
  • Zinc Sulfate

Substances

  • Zinc Oxide
  • polyacrylamide
  • Dextrans
  • Zinc Sulfate
  • Acrylic Resins

Grants and funding

This study was supported in part by the Ministry of the Education and Science of Ukraine, Project no. 0122U001818 and by National Research Foundation of Ukraine Project 2020.02/0022, Research program of the NAS of Ukraine (No. 0118U005468), Guangxi Innovation Driven Development Major Project (No. Guike AA20302013), Nanning Scientific Research and Technology Development Plan Project (No. RC20200001), Yongjiang Plan Project of Leading Talents of Innovation and Entrepreneurship in Nanning City (No. 2020024), Yulin City Science and Technology Transformation Project (No. 19040003).